Key Takeaways:
- A penetration test only covers the technical slice of a HIPAA risk analysis. Vendors should be scoping tests from your risk analysis findings and then feeding results back into the risk register.
- The difference between the discovery and attack phases separates a real penetration test from an automated scan with a report attached. Ask what happens between the two, including how the vendor handles a critical finding mid-engagement.
- Blackbox, greybox, and whitebox testing simulate different threats. Choose the style that matches whether your bigger concern is an outside attacker, a compromised account, or an insider.
- A proposed update to the HIPAA Security Rule would require annual penetration testing and semi-annual vulnerability scanning. It isn’t finalized, but it signals where regulators expect healthcare compliance security to go.
A HIPAA assessment tells you where your electronic protected health information (ePHI) is exposed, while a penetration test tells you whether that ePHI can be reached. Firms that sell both services often bundle them into one proposal, but the depth behind that penetration testing line item can vary more than expected. In another news note, federal regulators have already proposed making annual penetration testing a Security Rule requirement instead of an addressable safeguard, which means this shortlist decision will apply to more organizations soon. Before you sign with a provider, walk through what the engagement does, phase by phase.
A REAL SCOPE TRACES BACK TO THE RISK ANALYSIS
The HIPAA Security Rule calls for a risk analysis covering technical, physical, and administrative safeguards. A penetration test only reaches the technical piece, and only within whatever scope the two parties agree to test. A vendor combining HIPAA assessment work with healthcare penetration testing services should build that scope from the gaps the risk analysis already found, then feed test results back into the risk register. Even before asking about pricing, ask to see how those two documents connect.
THE FOUR TESTING PHASES SEPARATE A REAL TEST FROM A SCAN WITH A REPORT ATTACHED
Every credible penetration testing methodology moves through the same four phases: planning, discovery, attack, and documentation. Discovery runs automated scanning to build a baseline of possible vulnerabilities. Attack is where a person manually attempts to exploit what the scanner found, clears out false positives, and chases how far that access extends, including privilege escalation and movement across the network. A vendor that stops at discovery is really selling you a scan, not an actual test.
Questions to ask include what happens between those two phases and what happens if testers hit something critical during the engagement. A vendor with a mature process will pause immediately, report the finding, and let the client decide whether testing continues before anything else gets touched.
ePHI LIVES BEYOND THE NETWORK, AND SCOPE SHOULD FOLLOW IT
Patient portals, scheduling APIs, mobile check-in apps, and staff inboxes all touch ePHI, and all of them represent a potential route in. Healthcare penetration testing services built for medical data should be able to scope and test external and internal networks, web applications with and without credentials, APIs with and without credentials, mobile applications, phishing and vishing campaigns aimed at staff, and physical access to the facilities storing records. If a vendor’s proposal stops at the network layer, ask how the rest is covered.
BLACKBOX, GREYBOX, AND WHITEBOX TESTING SHOULD MATCH YOUR ACTUAL THREAT MODEL
Blackbox testing simulates an attacker who knows nothing about your environment beyond what’s public. It’s the most commonly requested style, and a reasonable default for a first engagement.
Greybox testing hands testers some credentials or internal access up front, the way a compromised account or an insider might operate, and it reaches deeper into scope faster.
Whitebox testing gives testers full documentation, network diagrams, and credentials, so they spend the engagement hunting for exploitable weaknesses instead of mapping the environment first.
The right style depends on which threat worries your organization most: an outside attacker, a compromised account, or a motivated insider.
REMEDIATION WINDOWS AND RE-TESTING ARE WHERE THE RISK LOWERS
A report full of findings does nothing for your risk posture until something gets fixed. Firms worth doing business with build remediation and re-testing into the engagement, typically a 30-to-90-day window depending on severity, and they update each finding’s status after remediation instead of quietly dropping it from the record. Ask whether re-testing is included or billed separately and ask whether findings stay in the final report even after they’re fixed. That second detail says more about a vendor’s rigor than almost anything else on the proposal.
Regulators are already pointing in this direction. A proposed update to the HIPAA Security Rule would require penetration testing at least once every 12 months and vulnerability scanning at least every six months, alongside multi-factor authentication and encryption requirements. The rule remains under review with no set finalization date, but treating testing as a one-time project instead of a standing program is a bet against where healthcare compliance security is headed.
ASK FOR THE METHODOLOGY BEFORE YOU ASK FOR THE QUOTE
The biggest firm on the market doesn’t necessarily fit every healthcare organization. A good shortlist should include vendors who can explain, in plain terms, how their HIPAA assessment work and their penetration testing connect, what happens inside each of the four phases, and what your team owns once the report is finalized. A vendor who isn’t able toanswer those questions probably doesn’t belong in consideration, regardless of how the proposal looks on paper.
